- Home
- ALLR vs PRSO Comparison
ALLR vs PRSO Comparison
Compare ALLR & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- PRSO
- Stock Information
- Founded
- ALLR 2004
- PRSO 2008
- Country
- ALLR United States
- PRSO United States
- Employees
- ALLR N/A
- PRSO N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- ALLR Health Care
- PRSO Technology
- Exchange
- ALLR Nasdaq
- PRSO Nasdaq
- Market Cap
- ALLR 4.0M
- PRSO 4.3M
- IPO Year
- ALLR N/A
- PRSO 2001
- Fundamental
- Price
- ALLR $0.87
- PRSO $0.93
- Analyst Decision
- ALLR
- PRSO Strong Buy
- Analyst Count
- ALLR 0
- PRSO 2
- Target Price
- ALLR N/A
- PRSO $3.38
- AVG Volume (30 Days)
- ALLR 660.5K
- PRSO 196.1K
- Earning Date
- ALLR 05-09-2025
- PRSO 05-12-2025
- Dividend Yield
- ALLR N/A
- PRSO N/A
- EPS Growth
- ALLR N/A
- PRSO N/A
- EPS
- ALLR N/A
- PRSO N/A
- Revenue
- ALLR N/A
- PRSO $15,626,000.00
- Revenue This Year
- ALLR N/A
- PRSO $3.96
- Revenue Next Year
- ALLR N/A
- PRSO $36.80
- P/E Ratio
- ALLR N/A
- PRSO N/A
- Revenue Growth
- ALLR N/A
- PRSO 35.50
- 52 Week Low
- ALLR $0.61
- PRSO $0.52
- 52 Week High
- ALLR $20.44
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- ALLR 36.97
- PRSO 53.81
- Support Level
- ALLR $1.02
- PRSO $0.80
- Resistance Level
- ALLR $1.06
- PRSO $1.03
- Average True Range (ATR)
- ALLR 0.08
- PRSO 0.09
- MACD
- ALLR -0.03
- PRSO -0.00
- Stochastic Oscillator
- ALLR 12.56
- PRSO 36.00
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.